Stamford, CT -- (SBWIRE) -- 12/03/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: HEDIRECTORY.COM INC (OTCMKTS:SEEK), Alliqua Inc (OTCMKTS:ALQAD), Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT), Liquidmetal Technologies Inc (OTCBB:LQMT)
THEDIRECTORY.COM INC (OTCMKTS:SEEK) ended higher +12.12% from its previous close of $0.0033 and complete the day at $0.0037. The total number of shares changed hands during the day was 57.95 million. After opening at $0.0035, the stock hit as high as $0.0039. However, it traded between $0.0001 and $0.0077 over the last twelve months.
Stocks graphical chart shows a bearish trend during its last one month’s trading session. It remained positive 428.57% during the previous three months trade. TheDirectory.com, Inc operates as a diversified local Internet search company. The company owns and operates a network of locally targeted, category specific search destinations through its local business search engine, TheDirectory.com. It sells listings on its local search network to local businesses and professionals primarily in the health, legal, and finance sectors.
For How Long SEEK will Fight for Profitability? Read This Trend Analysis report
Alliqua Inc (OTCMKTS:ALQAD) closed yesterday at $7.77, a -6.50% decrease. Around 254,930 shares were traded, beating an-average trading volume of 82,745 shares. The company is now valued at around $55.22 million. The stock opened the session at $8.35 and touched its highest price point at $8.44.
ALQAD’s lowest price point for the session stood at $7.40 and its 52 week price range stood at $1.66 - $8.44. Alliqua, Inc., a biopharmaceutical company, focuses on the development, manufacture, and distribution of proprietary transdermal wound care and drug delivery technologies. The company offers water content, electron beam cross-linked, and aqueous polymer hydrogels for wound care, medical diagnostics, transdermal drug delivery.
Has ALQAD Found The Bottom And Ready To Gain Momentum? Find Out Here
Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT) moved +10.53 percent higher at $0.945and traded between $0.86 and $0.94 after opening the day at $0.87. Its performance over the last five days remained 43.18%, which stands at 43.18% for a month. Going back further than one month, 1-year performance after recent close was 68.75%.
The company has a total of 139.97 million outstanding shares and its total market capitalization is $132.28 million. Its beta value stands at 0.54 times and earnings per share was -$0.10. Provectus Pharmaceuticals, Inc., a development-stage pharmaceutical company, engages in developing pharmaceuticals for oncology and dermatology indications. The company?s product line includes PV-10, a Phase II study completed drug candidate for metastatic melanoma, a Phase I study completed candidate for breast cancer.
For How Long PVCT’s Gloss will Attract Investors? Find out via this report
Liquidmetal Technologies Inc (OTCBB:LQMT)’s shares dropped, -3.71 percent from its previous close of $0.1807 to close at $0.174. The stock is up around 74.17% this year and 39.2% for the last 12 months. Around 2.77 million shares changed hands yesterday, higher from an-average trading volume of 2.44 million shares. Liquidmetal Technologies, Inc., a materials technology company, designs, develops, and sells products and components from bulk amorphous alloys worldwide. The company offers components for non-consumer electronic devices, including parts for high end printers, commercial imaging devices, aerospace and defense components, medical devices, automotive components, and industrial machines.
Will LQMT Get Buyers Even After The Recent Rally? Find Out Here
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)